Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 4720  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 »   Next article
 »   Previous article
 »   Table of Contents

 Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded213    
    Comments [Add]    
    Cited by others 10    

Recommend this journal


Year : 2003  |  Volume : 51  |  Issue : 2  |  Page : 237--240

Association of primary central nervous system lymphomas with the Epstein-Barr virus

1 Kidwai Memorial Institute of Oncology, NIMHANS, Bangalore, India
2 King Fahad National Centre for Children’s Cancer and Research, Kingdom of Saudi Arabia, Saudi Arabia
3 Department of Neuropathology, NIMHANS, Bangalore, India

Correspondence Address:
S K Shankar
Department of Neuropathology, NIMHANS, Bangalore-560029
Login to access the Email id

Source of Support: None, Conflict of Interest: None

PMID: 14571012

Rights and PermissionsRights and Permissions

The incidence of primary central nervous system lymphoma (PCNSL), previously a rare tumor, has increased significantly over the past few decades, partly due to the AIDS epidemic but also in immunocompetent individuals. Studies from Western countries have shown a consistent association of tumors occurring in immunocompromised individuals with the Epstein-Barr virus (EBV) suggesting an important role for the virus in the pathogenesis of these tumors, but an infrequent association of the virus with PCNSL in the immunocompetent host has also been noted. We studied 11 patients with PCNSL who had no evidence of an immunocompromised state. All the tumors were aggressive B cell lymphomas. EBV association was studied using EBER in-situ hybridization. 10 out of the 11 tumors were negative for EBV, indicating that tumors in immunocompetent individuals in developing countries are also infrequently EBV associated and that a different pathogenetic mechanism is operative in the evolution of these tumors.


Print this article     Email this article

Online since 20th March '04
Published by Wolters Kluwer - Medknow